Favipiravir: A new and emerging antiviral option in COVID-19

With over 16 million cases reported from across the globe, the SARS-CoV-2, a mere 125 microns in diameter, has left an indelible impact on our world. With the paucity of new drugs to combat this disease, the medical community is in a race to identify repurposed drugs that may be effective against th...

Descripción completa

Detalles Bibliográficos
Autores principales: Agrawal, Umang, Raju, Reyma, Udwadia, Zarir F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467067/
https://www.ncbi.nlm.nih.gov/pubmed/32895599
http://dx.doi.org/10.1016/j.mjafi.2020.08.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467067/
https://www.ncbi.nlm.nih.gov/pubmed/32895599
http://dx.doi.org/10.1016/j.mjafi.2020.08.004

Ejemplares similares